title: Potentiation of Glycine-Gated NR1/NR3A NMDA Receptors Relieves Ca-Dependent Outward Rectification.
abstract: Glycine has diverse functions within the mammalian central nervous system. It inhibits postsynaptic neurons via strychnine-sensitive glycine receptors (GlyRs) and enhances neuronal excitation through co-activation of N-methyl-D-aspartate (NMDA) receptors. Classical Ca(2+)-permeable NMDA receptors are composed of glycine-binding NR1 and glutamate-binding NR2 subunits, and hence require both glutamate and glycine for efficient activation. In contrast, recombinant receptors composed of NR1 and the glycine binding NR3A and/or NR3B subunits lack glutamate binding sites and can be activated by glycine alone. Therefore these receptors are also named "excitatory glycine receptors". Co-application of antagonists of the NR1 glycine-binding site or of the divalent cation Zn(2+) markedly enhances the glycine responses of these receptors. To gain further insight into the properties of these glycine-gated NMDA receptors, we investigated their current-voltage (I-V) dependence. Whole-cell current-voltage relations of glycine currents recorded from NR1/NR3B and NR1/NR3A/NR3B expressing oocytes were found to be linear under our recording conditions. In contrast, NR1/NR3A receptors displayed a strong outwardly rectifying I-V relation. Interestingly, the voltage-dependent inward current block was abolished in the presence of NR1 antagonists, Zn(2+) or a combination of both. Further analysis revealed that Ca(2+) (1.8 mM) present in our recording solutions was responsible for the voltage-dependent inhibition of ion flux through NR1/NR3A receptors. Since physiological concentrations of the divalent cation Mg(2+) did not affect the I-V dependence, our data suggest that relief of the voltage-dependent Ca(2+) block of NR1/NR3A receptors by Zn(2+) may be important for the regulation of excitatory glycinergic transmission, according to the Mg(2+)-block of conventional NR1/NR2 NMDA receptors.
authors.affiliation: Department of Neurochemistry, Max-Planck Institute for Brain Research Frankfurt am Main, Germany.
authors.forename: Christian
authors.initials: C
authors.lastname: Madry
authors.forename: Heinrich
authors.initials: H
authors.lastname: Betz
authors.forename: Jörg R P
authors.initials: JR
authors.lastname: Geiger
authors.forename: Bodo
authors.initials: B
authors.lastname: Laube
references.citation: J Neurosci. 2009 Feb 25;29(8):2371-83
references.pmid: 19244513
references.citation: J Biol Chem. 2005 Aug 19;280(33):29708-16
references.pmid: 15970596
references.citation: J Neurosci. 1995 Oct;15(10):6509-20
references.pmid: 7472413
references.citation: Neuron. 2000 Oct;28(1):165-81
references.pmid: 11086992
references.citation: Nat Rev Neurosci. 2005 Jun;6(6):449-62
references.pmid: 15891778
references.citation: Nature. 2002 Feb 14;415(6873):793-8
references.pmid: 11823786
references.citation: J Neurosci. 2006 Apr 26;26(17):4559-66
references.pmid: 16641235
references.citation: Neuron. 1997 Mar;18(3):493-503
references.pmid: 9115742
references.citation: Curr Opin Neurobiol. 2001 Jun;11(3):327-35
references.pmid: 11399431
references.citation: Mol Pharmacol. 2007 Dec;72(6):1535-44
references.pmid: 17878266
references.citation: Neuron. 1995 Jul;15(1):193-204
references.pmid: 7619522
references.citation: Neuropharmacology. 2004 Dec;47(7):994-1007
references.pmid: 15555634
references.citation: Biochem Biophys Res Commun. 2007 Mar 2;354(1):102-8
references.pmid: 17214961
references.citation: Proc Natl Acad Sci U S A. 1986 Sep;83(18):7104-8
references.pmid: 3529096
references.citation: Neuron. 2006 Nov 22;52(4):679-90
references.pmid: 17114051
references.citation: J Pharmacol Exp Ther. 2009 Dec;331(3):975-84
references.pmid: 19726695
references.citation: Pharmacol Rev. 1999 Mar;51(1):7-61
references.pmid: 10049997
references.citation: J Neurosci. 2006 Dec 20;26(51):13156-66
references.pmid: 17182766
references.citation: J Neurochem. 2006 Jun;97(6):1600-10
references.pmid: 16805771
references.citation: Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12563-8
references.pmid: 18711142
references.citation: J Physiol. 1995 Mar 15;483 ( Pt 3):613-9
references.pmid: 7776247
references.citation: J Biol Chem. 2008 Jan 4;283(1):37-46
references.pmid: 17959602
references.citation: J Neurosci. 2002 Dec 1;22(23):10209-16
references.pmid: 12451122
references.citation: Neuron. 1994 Jun;12(6):1291-300
references.pmid: 8011339
references.citation: Nature. 2006 Mar 23;440(7083):456-62
references.pmid: 16554805
references.citation: Nature. 2005 Nov 10;438(7065):185-92
references.pmid: 16281028
references.citation: J Neurophysiol. 2008 Jan;99(1):122-32
references.pmid: 18003876
references.citation: J Neurosci. 2001 Dec 1;21(23):RC185
references.pmid: 11717388
references.citation: Science. 1998 Jun 5;280(5369):1596-9
references.pmid: 9616121
references.citation: Neuron. 1996 Aug;17(2):343-52
references.pmid: 8780657
references.citation: Neuron. 2005 Mar 3;45(5):727-39
references.pmid: 15748848
references.citation: J Neurosci. 1998 Apr 15;18(8):2954-61
references.pmid: 9526012
references.citation: Nature. 1987 Feb 5-11;325(6104):529-31
references.pmid: 2433595
references.citation: Mol Pharmacol. 2007 Jan;71(1):112-22
references.pmid: 17047094
references.citation: Mol Pharmacol. 1998 May;53(5):933-41
references.pmid: 9584221
references.citation: Hear Res. 2000 Mar;141(1-2):117-28
references.pmid: 10713500
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14163-8
references.pmid: 18779583
references.citation: Hear Res. 2002 May;167(1-2):122-35
references.pmid: 12117536